Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Use</td><td align="left">Set of markers</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Detection of aggressive/nonaggressive cancer and adenoma</td><td align="left">BHLHE40, FOXP1, LOC285205, ITGA9, CTDSPL (RBSP3), FGF12   Sp = 94% Sn = 94% Ac = 94%</td></tr><tr><td align="center" colspan="2"><hr/></td></tr><tr><td align="left">Discrimination between aggressive cancer and nonaggressive cancer/adenoma</td><td align="left">LOC440944/SETD5, VHL, CLCN2, OSBPL10/ZNF860, LMCD1   Sp = 97% Sn = 100% Ac = 97%</td></tr><tr><td align="center" colspan="2"><hr/></td></tr><tr><td align="left">Discrimination between nonaggressive cancer and adenoma</td><td align="left">FAM19A4, CAND2, MAP4, KY, LRRC58   Sp = 73% Sn = 93% Ac = 83%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>Note. Sp/Sn/Ac: specificity/sensitivity/accuracy of the set. </td></tr></table>

Detection and discrimination of aggressive/nonaggressive prostate cancer and adenoma using the set of 16 selected markers.

Disease Markers

tab4

Table 4

Table 4: Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis 